🔎 Trials Near Me

Почетна › Беркитов лимфом › Arizona

Kliničke studije za Беркитов лимфом u državi Arizona

7 studija za Беркитов лимфом traži učesnike na lokacijama u državi Arizona.

Gradovi u državi Arizona

Zvanični tekst studije (na engleskom)

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

  • Banner Children's at Desert, Mesa
  • Phoenix Childrens Hospital, Phoenix
  • Banner University Medical Center - Tucson, Tucson
Тражи се учесникФаза 2
Узраст од 1 до 30 · Оба пола · Ажурирано 12. 11. 2026. · NCT04546399

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  • Banner Children's at Desert, Mesa
Тражи се учесникФаза 2
365 Days · Оба пола · Ажурирано 27. 10. 2026. · NCT06317662

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

  • Phoenix Childrens Hospital, Phoenix
  • Banner University Medical Center - Tucson, Tucson
Тражи се учесникФаза 2
366 Days – 46 Years · Оба пола · Ажурирано 27. 10. 2026. · NCT06124157

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

  • City of Hope at Phoenix, Phoenix
Тражи се учесникФаза 2
Узраст од 18 до 54 · Оба пола · Ажурирано 13. 10. 2026. · NCT06918431

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • Banner Children's at Desert, Mesa
  • Phoenix Childrens Hospital, Phoenix
  • Banner University Medical Center - Tucson, Tucson
Тражи се учесникФаза 3
365 Days – 25 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT03959085

Study of SGR-1505 in Mature B-Cell Neoplasms

  • Banner Health - MD Anderson Cancer Center, Gilbert
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 13. 2. 2026. · NCT05544019

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

  • Phoenix Children's Hospital, Phoenix
Тражи се учесникФаза 2
Узраст од 1 до 25 · Оба пола · Ажурирано 4. 5. 2025. · NCT03509961

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.